Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers L > Headlines for Lion Biotechnologies, Inc. > News item |
Lion Biotechnologies plans to conduct public offering of common shares
Offering conducted through bookrunners Jeffries, Cowen, Piper Jaffray
By Devika Patel
Knoxville, Tenn., Feb. 25 – Lion Biotechnologies, Inc. said it will price a public sale of common stock with a 30-day, 15% greenshoe.
Jefferies LLC, Cowen and Co., LLC and Piper Jaffray & Co. are the bookrunners. Roth Capital Partners, LLC is the co-manager.
Proceeds will be used offering for development of product candidates, clinical trials and general corporate and working capital purposes.
The biotechnology company is based in Woodland Hills, Calif.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.